Skip to main content
OpenTrials

Clinical trial condition

Esophageal Squamous Cell Carcinoma

Explore clinical trials studying Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

404 public trials 130 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Squamous Cell Carcinoma trial results

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Upmc Cancercenter Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 21 locations
View Trial Details
Completed

A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands

NCT01351103

Conditions
BRAF Mutant Colorectal Cancer, Breast Diseases, Breast Neoplasms, +35 more
Locations
  • UCLA School of Medicine Los Angeles, California, United States
  • Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Baltimore, Maryland, United States
  • Dana Farber Cancer Institute SC-7 Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Onc Dept. Ann Arbor, Michigan, United States
View all 20 locations
View Trial Details
Completed

A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China

NCT04121286

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical Collage Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View Trial Details
Completed

A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

NCT04704154

Conditions
Astrocytoma, Carcinoma, Carcinoma, Squamous Cell, +21 more
Locations
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Rocky Mountain Cancer Centers / Aurora, CO Aurora, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Sarah Cannon Cancer Center Nashville, Tennessee, United States
View all 34 locations
View Trial Details
Completed

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

NCT04925284

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Exelixis Clinical Site #48 Birmingham, Alabama, United States
  • Exelixis Clinical Site #20 Tucson, Arizona, United States
  • Exelixis Clinical Site#95 Tucson, Arizona, United States
  • Exelixis Clinical Site#58 Little Rock, Arkansas, United States
View all 95 locations
View Trial Details
Completed

Pre-Surgery If Needed for Oesophageal Cancer

NCT03937362

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations
  • Shanghai Chest Hospital Shanghai, China
  • Queen Mary Hospital Hong Kong
  • Erasmus MC Cancer Institute Rotterdam, Netherlands
  • Chang Gung Memorial Hospital Linkou District, Taiwan
View Trial Details
Completed

Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

NCT04732494

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Quanzhou First Hospital of Fujian Province Quanzhou, Fujian, China
  • First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Lanzhou University Second Hospital Gansu, China
View all 86 locations
View Trial Details

Related conditions